• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

首次使用标准直线加速器实现实时图像引导自适应放疗的临床应用。

The first clinical implementation of real-time image-guided adaptive radiotherapy using a standard linear accelerator.

机构信息

University of Sydney, Australia.

University of Sydney, Australia.

出版信息

Radiother Oncol. 2018 Apr;127(1):6-11. doi: 10.1016/j.radonc.2018.01.001. Epub 2018 Feb 7.

DOI:10.1016/j.radonc.2018.01.001
PMID:29428258
Abstract

PURPOSE

Until now, real-time image guided adaptive radiation therapy (IGART) has been the domain of dedicated cancer radiotherapy systems. The purpose of this study was to clinically implement and investigate real-time IGART using a standard linear accelerator.

MATERIALS/METHODS: We developed and implemented two real-time technologies for standard linear accelerators: (1) Kilovoltage Intrafraction Monitoring (KIM) that finds the target and (2) multileaf collimator (MLC) tracking that aligns the radiation beam to the target. Eight prostate SABR patients were treated with this real-time IGART technology. The feasibility, geometric accuracy and the dosimetric fidelity were measured.

RESULTS

Thirty-nine out of forty fractions with real-time IGART were successful (95% confidence interval 87-100%). The geometric accuracy of the KIM system was -0.1 ± 0.4, 0.2 ± 0.2 and -0.1 ± 0.6 mm in the LR, SI and AP directions, respectively. The dose reconstruction showed that real-time IGART more closely reproduced the planned dose than that without IGART. For the largest motion fraction, with real-time IGART 100% of the CTV received the prescribed dose; without real-time IGART only 95% of the CTV would have received the prescribed dose.

CONCLUSION

The clinical implementation of real-time image-guided adaptive radiotherapy on a standard linear accelerator using KIM and MLC tracking is feasible. This achievement paves the way for real-time IGART to be a mainstream treatment option.

摘要

目的

到目前为止,实时图像引导自适应放疗(IGART)一直是专门的癌症放疗系统的领域。本研究的目的是使用标准线性加速器临床实施和研究实时 IGART。

材料/方法:我们为标准线性加速器开发并实现了两种实时技术:(1)千伏分时段监控(KIM),用于找到目标,以及(2)多叶准直器(MLC)跟踪,用于将辐射束对准目标。8 例前列腺 SABR 患者接受了这种实时 IGART 技术治疗。测量了可行性、几何精度和剂量学保真度。

结果

实时 IGART 治疗的 40 个分次中有 39 个成功(95%置信区间 87-100%)。KIM 系统的几何精度在 LR、SI 和 AP 方向上分别为-0.1±0.4、0.2±0.2 和-0.1±0.6mm。剂量重建表明,实时 IGART 比没有 IGART 的情况下更能准确地复制计划剂量。对于运动幅度最大的分次,实时 IGART 可使 100%CTV 接受规定剂量;而没有实时 IGART 的情况下,只有 95%CTV 会接受规定剂量。

结论

使用 KIM 和 MLC 跟踪在标准线性加速器上实施实时图像引导自适应放疗是可行的。这一成就为实时 IGART 成为主流治疗选择铺平了道路。

相似文献

1
The first clinical implementation of real-time image-guided adaptive radiotherapy using a standard linear accelerator.首次使用标准直线加速器实现实时图像引导自适应放疗的临床应用。
Radiother Oncol. 2018 Apr;127(1):6-11. doi: 10.1016/j.radonc.2018.01.001. Epub 2018 Feb 7.
2
The accuracy and precision of the KIM motion monitoring system used in the multi-institutional TROG 15.01 Stereotactic Prostate Ablative Radiotherapy with KIM (SPARK) trial.在多机构 TROG 15.01 立体定向前列腺消融放疗与 KIM(SPARK)试验中使用的 KIM 运动监测系统的准确性和精密度。
Med Phys. 2019 Nov;46(11):4725-4737. doi: 10.1002/mp.13784. Epub 2019 Sep 20.
3
Real-Time 3D Image Guidance Using a Standard LINAC: Measured Motion, Accuracy, and Precision of the First Prospective Clinical Trial of Kilovoltage Intrafraction Monitoring-Guided Gating for Prostate Cancer Radiation Therapy.基于 LINAC 的实时 3D 图像引导:首项千伏级术中实时监控引导门控前列腺癌放射治疗前瞻性临床试验的运动测量、准确性和精密度。
Int J Radiat Oncol Biol Phys. 2016 Apr 1;94(5):1015-21. doi: 10.1016/j.ijrobp.2015.10.009. Epub 2016 Mar 17.
4
The first clinical implementation of a real-time six degree of freedom target tracking system during radiation therapy based on Kilovoltage Intrafraction Monitoring (KIM).基于千伏级分次内监测(KIM)的放射治疗期间实时六自由度目标跟踪系统的首次临床应用。
Radiother Oncol. 2017 Apr;123(1):37-42. doi: 10.1016/j.radonc.2017.02.013. Epub 2017 Mar 22.
5
Simulated multileaf collimator tracking for stereotactic liver radiotherapy guided by kilovoltage intrafraction monitoring: Dosimetric gain and target overdose trends.基于千伏级术中实时监测的立体定向肝脏放疗中多叶准直器的模拟追踪:剂量学增益和靶区超量趋势。
Radiother Oncol. 2020 Mar;144:93-100. doi: 10.1016/j.radonc.2019.11.008. Epub 2019 Nov 28.
6
The first clinical treatment with kilovoltage intrafraction monitoring (KIM): a real-time image guidance method.首次采用千伏级分次内监测(KIM)的临床治疗:一种实时图像引导方法。
Med Phys. 2015 Jan;42(1):354-8. doi: 10.1118/1.4904023.
7
Is multileaf collimator tracking or gating a better intrafraction motion adaptation strategy? An analysis of the TROG 15.01 stereotactic prostate ablative radiotherapy with KIM (SPARK) trial.多叶准直器跟踪或门控是否是更好的分次内运动适应策略?TROG 15.01 立体定向前列腺消融放疗与 KIM(SPARK)试验的分析。
Radiother Oncol. 2020 Oct;151:234-241. doi: 10.1016/j.radonc.2020.08.010. Epub 2020 Aug 20.
8
Study protocol of the LARK (TROG 17.03) clinical trial: a phase II trial investigating the dosimetric impact of Liver Ablative Radiotherapy using Kilovoltage intrafraction monitoring.LARK(TROG 17.03)临床试验研究方案:一项使用千伏级术中实时监测评估肝消融放射治疗剂量学影响的 II 期临床试验。
BMC Cancer. 2021 May 3;21(1):494. doi: 10.1186/s12885-021-08184-x.
9
Kilovoltage intrafraction monitoring during normofractionated prostate cancer radiotherapy.常规分割前列腺癌放疗期间的千伏级分次内监测
Cancer Radiother. 2020 Apr;24(2):99-105. doi: 10.1016/j.canrad.2019.11.001. Epub 2020 Mar 19.
10
Multileaf Collimator Tracking Improves Dose Delivery for Prostate Cancer Radiation Therapy: Results of the First Clinical Trial.多叶准直器跟踪技术可提高前列腺癌放射治疗的剂量传递:首次临床试验结果。
Int J Radiat Oncol Biol Phys. 2015 Aug 1;92(5):1141-1147. doi: 10.1016/j.ijrobp.2015.04.024. Epub 2015 Apr 17.

引用本文的文献

1
Patient-specific prostate segmentation in kilovoltage images for radiation therapy intrafraction monitoring via deep learning.通过深度学习在千伏图像中进行患者特异性前列腺分割以用于放射治疗分次内监测。
Commun Med (Lond). 2025 Jun 3;5(1):212. doi: 10.1038/s43856-025-00935-2.
2
Predicting Radiation Esophagitis in Patients Undergoing Synchronous Boost Radiotherapy Post-Breast-Conserving Surgery.保乳手术后同步加量放疗患者放射性食管炎的预测
Dose Response. 2025 Apr 15;23(2):15593258251335802. doi: 10.1177/15593258251335802. eCollection 2025 Apr-Jun.
3
The TROG 15.01 stereotactic prostate adaptive radiotherapy utilizing kilovoltage intrafraction monitoring (SPARK) clinical trial database.
TROG 15.01利用千伏分次内监测的立体定向前列腺自适应放疗(SPARK)临床试验数据库。
Med Phys. 2025 Mar;52(3):1941-1949. doi: 10.1002/mp.17529. Epub 2024 Nov 23.
4
Accuracy of four models and update strategies to estimate liver tumor motion from external respiratory motion.四种模型及更新策略从外部呼吸运动估计肝脏肿瘤运动的准确性
Front Oncol. 2024 Sep 24;14:1470650. doi: 10.3389/fonc.2024.1470650. eCollection 2024.
5
Radio-opaque contrast agents for liver cancer targeting with KIM during radiation therapy (ROCK-RT): an observational feasibility study.用于肝癌放疗中 KIM 靶向的放射不透性对比剂(ROCK-RT):一项观察性可行性研究。
Radiat Oncol. 2024 Oct 8;19(1):139. doi: 10.1186/s13014-024-02524-4.
6
Comparative analysis of delivered and planned doses in target volumes for lung stereotactic ablative radiotherapy.肺立体定向消融放疗中靶区的实际剂量与计划剂量的比较分析。
Radiat Oncol. 2024 Aug 16;19(1):110. doi: 10.1186/s13014-024-02505-7.
7
Deformable dose accumulation is required for adaptive radiotherapy practice.适形放疗实践需要可变形剂量累积。
J Appl Clin Med Phys. 2024 Aug;25(8):e14457. doi: 10.1002/acm2.14457. Epub 2024 Jul 19.
8
Super-resolution neural networks improve the spatiotemporal resolution of adaptive MRI-guided radiation therapy.超分辨率神经网络提高了自适应磁共振成像引导放射治疗的时空分辨率。
Commun Med (Lond). 2024 Apr 4;4(1):64. doi: 10.1038/s43856-024-00489-9.
9
Predicting cervical cancer target motion using a multivariate regression model to enable patient selection for adaptive external beam radiotherapy.使用多变量回归模型预测宫颈癌靶区运动,以实现适应性外照射放疗的患者选择。
Phys Imaging Radiat Oncol. 2024 Feb 15;29:100554. doi: 10.1016/j.phro.2024.100554. eCollection 2024 Jan.
10
Inter-Breath-Hold Geometric and Dosimetric Variations in Organs at Risk during Pancreatic Stereotactic Body Radiotherapy: Implications for Adaptive Radiation Therapy.胰腺癌立体定向体部放疗期间屏气间隔期危及器官的几何形状和剂量学变化:对自适应放射治疗的影响
Cancers (Basel). 2023 Aug 30;15(17):4332. doi: 10.3390/cancers15174332.